IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL-42X phase 2 clinical trial presentation, page-38

  1. 1,211 Posts.
    lightbulb Created with Sketch. 526
    Surely you agree that for some people, 42x would be the preferred method of treatment though? The global market for OSA is $10b per year. If IHL takes even 1% of that we are talking $100m USD annual revenue. You don't think that's perceivable?
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.